These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10669560)

  • 1. A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).
    Lovell PJ; Bromidge SM; Dabbs S; Duckworth DM; Forbes IT; Jennings AJ; King FD; Middlemiss DN; Rahman SK; Saunders DV; Collin LL; Hagan JJ; Riley GJ; Thomas DR
    J Med Chem; 2000 Feb; 43(3):342-5. PubMed ID: 10669560
    [No Abstract]   [Full Text] [Related]  

  • 2. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y; Böttcher H; Harting J; Greiner H; van Amsterdam C; Cremers T; Sundell S; März J; Rautenberg W; Wikström H
    J Med Chem; 2000 Feb; 43(3):517-25. PubMed ID: 10669578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.
    Tsai Y; Dukat M; Slassi A; MacLean N; Demchyshyn L; Savage JE; Roth BL; Hufesein S; Lee M; Glennon RA
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2295-9. PubMed ID: 11055342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT₆ receptor antagonists.
    Yoo E; Hayat F; Rhim H; Park Choo HY
    Bioorg Med Chem; 2012 Apr; 20(8):2707-12. PubMed ID: 22405919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
    Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
    Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist.
    Forbes IT; Dabbs S; Duckworth DM; Jennings AJ; King FD; Lovell PJ; Brown AM; Collin L; Hagan JJ; Middlemiss DN; Riley GJ; Thomas DR; Upton N
    J Med Chem; 1998 Feb; 41(5):655-7. PubMed ID: 9513592
    [No Abstract]   [Full Text] [Related]  

  • 7. N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT₆ receptor antagonists.
    Nirogi RV; Konda JB; Kambhampati R; Shinde A; Bandyala TR; Gudla P; Kandukuri KK; Jayarajan P; Kandikere V; Dubey PK
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6980-5. PubMed ID: 23036955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.
    Bromidge SM; Clarke SE; King FD; Lovell PJ; Newman H; Riley G; Routledge C; Serafinowska HT; Smith DR; Thomas DR
    Bioorg Med Chem Lett; 2002 May; 12(10):1357-60. PubMed ID: 11992776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
    Holenz J; Mercè R; Díaz JL; Guitart X; Codony X; Dordal A; Romero G; Torrens A; Mas J; Andaluz B; Hernández S; Monroy X; Sánchez E; Hernández E; Pérez R; Cubí R; Sanfeliu O; Buschmann H
    J Med Chem; 2005 Mar; 48(6):1781-95. PubMed ID: 15771424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Thia-4,7-diaza-spiro[4.4]nonane-3,6-dione: a structural motif for 5-hydroxytryptamine 6 receptor antagonism.
    Hostetler G; Dunn D; McKenna BA; Kopec K; Chatterjee S
    Chem Biol Drug Des; 2014 Feb; 83(2):149-53. PubMed ID: 24119217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
    van Loevezijn A; Venhorst J; Iwema Bakker WI; de Korte CG; de Looff W; Verhoog S; van Wees JW; van Hoeve M; van de Woestijne RP; van der Neut MA; Borst AJ; van Dongen MJ; de Bruin NM; Keizer HG; Kruse CG
    J Med Chem; 2011 Oct; 54(20):7030-54. PubMed ID: 21866910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM; Blaney FE; Davies S; Duckworth DM; Ham P; Jenkins S; Jennings AJ; Joiner GF; King FD; Mulholland KR; Wyman PA; Hagan JJ; Hatcher J; Jones BJ; Middlemiss DN; Price GW; Riley G; Roberts C; Routledge C; Selkirk J; Slade PD
    J Med Chem; 1998 Apr; 41(8):1218-35. PubMed ID: 9548813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
    Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
    J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological activity of metabolites of the 5-HT(4) receptor antagonist SB-207266.
    Fedouloff M; Hossner F; Voyle M; Ranson J; Powles J; Riley G; Sanger G
    Bioorg Med Chem; 2001 Aug; 9(8):2119-28. PubMed ID: 11504648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).
    Bromidge SM; Clarke SE; Gager T; Griffith K; Jeffrey P; Jennings AJ; Joiner GF; King FD; Lovell PJ; Moss SF; Newman H; Riley G; Rogers D; Routledge C; Serafinowska H; Smith DR
    Bioorg Med Chem Lett; 2001 Jan; 11(1):55-8. PubMed ID: 11140733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonist.
    Stean TO; Hirst WD; Thomas DR; Price GW; Rogers D; Riley G; Bromidge SM; Serafinowska HT; Smith DR; Bartlett S; Deeks N; Duxon M; Upton N
    Pharmacol Biochem Behav; 2002 Apr; 71(4):645-54. PubMed ID: 11888556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.
    Ivachtchenko AV; Mitkin OD; Tkachenko SE; Okun IM; Kysil VM
    Eur J Med Chem; 2010 Feb; 45(2):782-9. PubMed ID: 19939513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.
    Corbett DF; Heightman TD; Moss SF; Bromidge SM; Coggon SA; Longley MJ; Roa AM; Williams JA; Thomas DR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4014-8. PubMed ID: 16002289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.